Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

Angina Market Growth Analysis: How Will Revenue Expand During The Forecast Period?

The market for angina treatments has experienced robust expansion historically and is projected to continue this upward trend. Having reached $11.36 billion in 2025, it’s anticipated to further increase to $12.05 billion by 2026, reflecting a compound annual growth rate of 6.1%. Key factors contributing to this expansion during the previous period included the increasing incidence of cardiovascular ailments, the widespread availability of medications like beta blockers and nitrates, the development of specialized cardiac care facilities within hospitals, a surge in diagnostic procedures, and the overall growth within the cardiology sector.

The

angina

market is projected for considerable expansion over the coming years, reaching an estimated value of $14.84 billion by 2030. This growth trajectory is underpinned by a compound annual growth rate (CAGR) of 5.3%, fueled by several key drivers. These include a heightened demand for tailored cardiovascular treatments, a greater prevalence of minimally invasive cardiac interventions, the increasing integration of digital tools for cardiac health monitoring, the broader implementation of cardiac prevention initiatives, and ongoing progress in the development of new cardiovascular medications. Furthermore, the upcoming period will likely witness significant trends such as a rise in the utilization of multifaceted drug regimens, an increased application of extended-release nitrate formulations, a more pronounced focus on proactive cardiac health management, the diversification of interventional therapeutic avenues, and an elevated commitment to managing patient lifestyles and associated risk factors.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=16337&type=smp

Angina Market Demand Drivers: What Is Fueling Industry Growth?

The increasing incidence of heart and blood vessel ailments, encompassing conditions like coronary heart disease, heart failure, and stroke, is anticipated to be a significant catalyst for the expansion of the angina market. This escalating trend in cardiovascular diseases is primarily attributed to an aging global population and a greater susceptibility to controllable risk factors, including unhealthy dietary habits, sedentary lifestyles, and the use of tobacco. Consequently, the heightened occurrence of cardiovascular issues fuels the demand for angina therapies, as these ailments often present with chest pain that necessitates medical intervention for symptom alleviation and the prevention of further complications. Illustrating this, data from the Centers for Disease Control and Prevention indicated a rise in deaths related to cardiovascular diseases in the U.S., climbing from 371,506 in 2022 to 919,032 in 2023. Thus, the growing burden of cardiovascular diseases is directly contributing to the market’s advancement in angina treatments.

Angina Market Segment Landscape: Which Areas Lead Market Development?

The angina market covered in this report is segmented –

1) By Type: Angina Pectoris, Unstable Angina, Prinzmetal Angina, Other Types

2) By Treatment: Lifestyle Changes, Medications, Angioplasty And Stenting, Coronary Bypass Surgery, Other Treatments

3) By Drug Class: Beta Blockers, Nitrates And Calcium Channel Blockers, Angiotensin-Converting Enzyme Inhibitors, Other Drug Classes

4) By Application: Clinics, Hospitals, Other Applications

Subsegments:

1) By Angina Pectoris: Stable Angina, Chronic Stable Angina, Effort-Induced Angina, Variant Or Microvascular Angina

2) By Unstable Angina: Acute Unstable Angina, Pre-Infarction Angina, Rest Angina

3) By Prinzmetal Angina: Vasospastic Angina, Coronary Artery Spasm-Induced Angina, Variant Angina

4) By Other Types: Nocturnal Angina, Post-Infarction Angina, Angina With Silent Myocardial Ischemia, Angina Due To Aortic Stenosis Or Valve Disease

Angina Market Innovation Trends: Which Developments Are Transforming The Industry?

In the landscape of the angina market, leading pharmaceutical entities are actively engaged in the creation of novel therapeutic agents, such as metoprolol tartrate tablets. These advancements aim to deliver more potent and precise interventions for individuals afflicted with coronary artery disease (CAD) and its associated ailments. Metoprolol tartrate tablets represent a widely recognized class of pharmaceuticals employed in the management of diverse cardiac issues, encompassing angina (discomfort in the chest), hypertension (elevated blood pressure), and cardiac insufficiency. To illustrate, in April of 2023, Zydus, a pharmaceutical firm originating from India, secured definitive authorization from the U.S. Food and Drug Administration (US-FDA). This approval empowers Zydus to produce and distribute its generic formulation of Metoprolol Tartrate Tablets USP, available in dosages of 25 mg, 50 mg, and 100 mg. Metoprolol itself functions as a beta-blocker, a medication utilized for a spectrum of cardiovascular concerns, including high blood pressure (hypertension) and chest pain (angina), and is also prescribed to enhance recovery outcomes following a myocardial infarction.

Angina Market Industry Leaders And Market Competition

Major companies operating in the angina market are Pfizer Inc., Bayer AG, AstraZeneca PLC, Merck & Co Inc., Sanofi S.A., Novartis AG, GlaxoSmithKline Plc, Eli Lilly and Company, Amgen Inc., Gilead Sciences Inc., Otsuka Pharmaceutical Co Ltd, Bristol-Myers Squibb Company, Boehringer Ingelheim GmbH, Abbott Laboratories, Daiichi Sankyo Company Ltd, Takeda Pharmaceutical Company Limited, Cipla Limited, Sun Pharmaceutical Industries Ltd, Zydus Cadila Healthcare Ltd, Astellas Pharma Inc., Amarin Corporation, Torrent Pharmaceuticals Ltd

Access The Complete Angina Market Report:

https://www.thebusinessresearchcompany.com/report/angina-global-market-report

Angina Market Regional Analysis: Which Region Leads By Revenue?

North Americawas the largest region in the angina market in 2025. Asia-Pacificis expected to be the fastest-growing region in the forecast period. The regions covered in the angina market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model